Last Updated on: 3rd June 2025, 05:49 pm
4D Medicine Limited, a UK leader in biomaterial innovation for surgical and orthopaedic applications, is proud to announce its participation as an exhibitor at Orthopaedic Manufacturing & Technology Exposition and Conference (OMTEC) 2025. The event is scheduled for 18–19 June at the Donald E. Stephens Convention Center in Chicago, Illinois.
Delegates will have the opportunity to meet the 4D Medicine team at Booth #558, where the company will highlight 4Degra®, a pioneering bioabsorbable polymer system. Based on proprietary polycarbonate urethane chemistry, this platform is tailored to support the complex needs of soft tissue repair and regenerative procedures in orthopaedics, spinal surgery, and trauma.
In addition, 4D Medicine will be actively engaging with potential distribution and commercial partners for the DegraFix™ Interference Screw, an advanced soft tissue fixation solution. Designed for improved biocompatibility and reliable resorption, DegraFix™ aims to give surgeons greater assurance over long-term clinical outcomes. The product marks the beginning of a future pipeline of novel fixation devices.
“We are excited to engage with industry leaders and investors at OMTEC 2025,” said Phil Smith, CEO of 4D Medicine Limited. “Our materials offer unique advantages in terms of processibility, biocompatibility, and regenerative potential. We look forward to exploring strategic partnerships that will accelerate commercialization and expand clinical impact.”
To arrange a meeting with the team during the event, attendees are encouraged to email the 4D Medicine business development team at info@4dmedicine.co.uk.
For further details on 4D Medicine and its biomaterial technologies, please visit www.4dmedicine.co.uk.
